EP4138818
Inndælanleg samsetning
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.8.2021EP published:
21.8.2024EP application number:
21769080.9
EP translation filed:
27.9.2024Grant published:
15.11.2024EPO information:
European Patent Register
Max expiry date:
19.8.2041Expiry date:
19.8.2026Next due date:
31.8.2026
Title in English:
INJECTABLE FORMULATIONLanguage of the patent:
English
Timeline
Today
20.8.2021EP application
21.8.2024EP Publication
27.9.2024Translation submitted
15.11.2024Registration published
19.8.2026Expires
Owner
Name:
Cybin UK LtdAddress:
50 Featherstone Street, London EC1Y 8RT, GB
Inventor
Name:
LAYZELL, Marie ClaireAddress:
London EC2A 4BX, GB
Name:
RENNIE, James MaxwellAddress:
London EC2A 4BX, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202013571Date:
28.8.2020Country:
GB
Number:
202017006115Date:
28.8.2020Country:
US
Classification
Categories:
A61K 31/4045, A61P 25/22, A61K 47/12, A61K 9/08, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 1.8.2025
Expires: 19.8.2026
Payer: Árnason Faktor ehf.